| Vertex Pharmaceuticals (CH) GmbH - Orkambi 100 mg lumacaftor / 125 mg ivacaftor, Granulat |
| 67395 | | 01 | | Orkambi 100 mg lumacaftor / 125 mg ivacaftor | | Granulat | | R07AX30 | | Ivacaftor and Lumacaftor | | 23.12.2019 | | |
|
| Composition |
| lumacaftorum 100 mg, ivacaftorum 125 mg, hypromellosi acetas succinas, natrii laurilsulfas, carmellosum natricum conexum, cellulosum microcristallinum, povidonum K 30 ad granulatum pro charta corresp. natrium max. 0.89 mg. |
| Packungsbestandteile |
| Granulate | | | | | | | | Active Agent | Dose |
|---|
| Ivacaftorum | 125 mg | | Lumacaftorum | 100 mg |
| | BAG: Active Agent | Dose |
|---|
| Ivacaftorum | 125 mg | | Lumacaftorum | 100 mg |
| | | | Inactive agents | Dose |
|---|
| Ad Granulatum | | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | Hypromellosi Acetas Succinas | | | Natrii Laurilsulfas | | | Povidonum K | 30 |
| |
|
|
